TY - JOUR
T1 - A minimal stress model for the assessment of electroacupuncture analgesia in rats under halothane
AU - Wen, Yeong-Ray
AU - Yeh, Geng Chang
AU - Shyu, Bai Chuang
AU - Ling, Qing Dong
AU - Wang, Kuo Ching
AU - Chen, Ta Liang
AU - Sun, Wei Zen
N1 - Funding Information:
The authors thank Yi-Hao Chang for technical assistance. Funding supports are research grants No. 8302-89-0208-01 and 8302-90-0208-01 (to Dr. Wen) from the Shin-Kong Wu Ho-Su Memorial Hospital.
PY - 2007/10
Y1 - 2007/10
N2 - The use of anesthetics in acupuncture analgesia is controversial. We evaluate a steady-state light anesthesia model to test whether minimal stress manipulation and reliable measurement of analgesia could be simultaneously achieved during electroacupuncture (EA) in animals. A series of experiments were performed. Firstly, EA compliance and tail-flick latencies (TFL) were compared in rats under 0.1%, 0.3%, 0.5%, 0.7%, or 1.1% halothane for 120 min. Under 0.5% halothane, TFL were then measured in groups receiving EA at intensity of 3, 10 or 20 volt (V), 1 or 2 mg/kg morphine, 20 V EA plus naloxone, or control. Subsequently, the effect of EA on formalin-induced hyperalgesia was tested and c-fos expression in the spinal dorsal horn was analyzed. Rats exhibited profound irritable behaviors and highly variable TFL under 0.1% or 0.3% halothane, as well as a time-dependent increase of TFL under 0.7% or 1.1% halothane. TFL remained constant at 0.5% halothane, and needle insertion and electrical stimulation were well tolerated. Under 0.5% halothane, EA increased TFL and suppressed formalin-induced hyperalgesia in an intensity-dependent and naloxone-reversible manner. EA of 20 V prolonged TFL by 74%, suppressed formalin-induced hyperalgesia by 32.6% and decreased c-fos expression by 29.7% at the superficial and deep dorsal horn with statistically significant difference. In conclusion, 0.5% halothane provides a steady-state anesthetic level which enables the humane application of EA stimulus with the least interference on analgesic assessment. This condition serves as a minimal stress EA model in animals devoid of stress-induced analgesia while maintaining physiological and biochemical response in the experiment.
AB - The use of anesthetics in acupuncture analgesia is controversial. We evaluate a steady-state light anesthesia model to test whether minimal stress manipulation and reliable measurement of analgesia could be simultaneously achieved during electroacupuncture (EA) in animals. A series of experiments were performed. Firstly, EA compliance and tail-flick latencies (TFL) were compared in rats under 0.1%, 0.3%, 0.5%, 0.7%, or 1.1% halothane for 120 min. Under 0.5% halothane, TFL were then measured in groups receiving EA at intensity of 3, 10 or 20 volt (V), 1 or 2 mg/kg morphine, 20 V EA plus naloxone, or control. Subsequently, the effect of EA on formalin-induced hyperalgesia was tested and c-fos expression in the spinal dorsal horn was analyzed. Rats exhibited profound irritable behaviors and highly variable TFL under 0.1% or 0.3% halothane, as well as a time-dependent increase of TFL under 0.7% or 1.1% halothane. TFL remained constant at 0.5% halothane, and needle insertion and electrical stimulation were well tolerated. Under 0.5% halothane, EA increased TFL and suppressed formalin-induced hyperalgesia in an intensity-dependent and naloxone-reversible manner. EA of 20 V prolonged TFL by 74%, suppressed formalin-induced hyperalgesia by 32.6% and decreased c-fos expression by 29.7% at the superficial and deep dorsal horn with statistically significant difference. In conclusion, 0.5% halothane provides a steady-state anesthetic level which enables the humane application of EA stimulus with the least interference on analgesic assessment. This condition serves as a minimal stress EA model in animals devoid of stress-induced analgesia while maintaining physiological and biochemical response in the experiment.
KW - Electroacupuncture
KW - Formalin
KW - Halothane
KW - Model
KW - c-Fos
UR - http://www.scopus.com/inward/record.url?scp=34547394285&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547394285&partnerID=8YFLogxK
U2 - 10.1016/j.ejpain.2006.11.003
DO - 10.1016/j.ejpain.2006.11.003
M3 - Article
C2 - 17218131
AN - SCOPUS:34547394285
SN - 1090-3801
VL - 11
SP - 733
EP - 742
JO - European Journal of Pain
JF - European Journal of Pain
IS - 7
ER -